{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:19:32Z","timestamp":1773800372847,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470319"],"award-info":[{"award-number":["81470319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91642110"],"award-info":[{"award-number":["91642110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2014HP003"],"award-info":[{"award-number":["ZR2014HP003"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2014HM067"],"award-info":[{"award-number":["ZR2014HM067"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.humimm.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T21:22:19Z","timestamp":1509484939000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia"],"prefix":"10.1016","volume":"79","author":[{"given":"Amin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.humimm.2017.10.013_b0005","doi-asserted-by":"crossref","first-page":"e78582.11","DOI":"10.1371\/journal.pone.0078582","article-title":"A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib","volume":"8","author":"Augis","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.humimm.2017.10.013_b0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/pgs.13.222","article-title":"MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis","volume":"15","author":"Zu","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.humimm.2017.10.013_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.humimm.2017.10.013_b0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2014.08.010","article-title":"Structure, function, and resistance in chronic myeloid leukemia","volume":"26","author":"Radich","year":"2014","journal-title":"Cancer cell"},{"issue":"2","key":"10.1016\/j.humimm.2017.10.013_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18553\/jmcsp.2015.21.2.114","article-title":"Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors","volume":"21","author":"Ursan","year":"2015","journal-title":"J. Managed Care Specialty Pharm."},{"issue":"4","key":"10.1016\/j.humimm.2017.10.013_b0030","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.7314\/APJCP.2016.17.4.2265","article-title":"The rs61764370 functional variant in the KRAS oncogene is associated with chronic myeloid leukemia risk in women","volume":"17","author":"Gutierrez-Malacatt","year":"2016","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"issue":"2","key":"10.1016\/j.humimm.2017.10.013_b0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mole. cell"},{"issue":"6","key":"10.1016\/j.humimm.2017.10.013_b0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.humimm.2017.10.013_b0045","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Annals Rheumatic Dis."},{"issue":"6","key":"10.1016\/j.humimm.2017.10.013_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/PPO.0000000000000004","article-title":"Complex roles of inflammasomes in carcinogenesis","volume":"19","author":"Drexler","year":"2013","journal-title":"Cancer J."},{"issue":"4","key":"10.1016\/j.humimm.2017.10.013_b0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","article-title":"Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma","volume":"25","author":"Verma","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"11","key":"10.1016\/j.humimm.2017.10.013_b0060","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/carcin\/bgs256","article-title":"Genetic variation and alterations of genes involved in NFkappaB\/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer","volume":"33","author":"Ungerback","year":"2012","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.humimm.2017.10.013_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10428194.2011.621566","article-title":"Interleukin-6 plasma levels are modulated by a polymorphism in the NF-kappaB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma","volume":"53","author":"Giachelia","year":"2012","journal-title":"Leukemia Lymphoma"},{"issue":"1","key":"10.1016\/j.humimm.2017.10.013_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00262-005-0688-z","article-title":"Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type","volume":"55","author":"Pratesi","year":"2006","journal-title":"Cancer Immunol., Immunother.: CII"},{"issue":"7","key":"10.1016\/j.humimm.2017.10.013_b0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/02841860902878145","article-title":"Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study","volume":"48","author":"Farjadfar","year":"2009","journal-title":"Acta Oncol. (Stockholm, Sweden)"},{"issue":"1","key":"10.1016\/j.humimm.2017.10.013_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gene.2013.01.025","article-title":"Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population","volume":"519","author":"Jaiswal","year":"2013","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.humimm.2017.10.013_b0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.humimm.2013.04.029","article-title":"Alleles and genotypes of polymorphisms of IL-18, TNF-alpha and IFN-gamma are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil","volume":"74","author":"Teixeira","year":"2013","journal-title":"Human Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2017.10.013_b0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/annonc\/mdi184","article-title":"Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype","volume":"16","author":"Ruzzo","year":"2005","journal-title":"Annals Oncol.: Official J. Eur. Soc. Med. Oncol."},{"issue":"3","key":"10.1016\/j.humimm.2017.10.013_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clon.2008.01.003","article-title":"Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population","volume":"20","author":"Zhu","year":"2008","journal-title":"Clin. Oncol. (Royal College of Radiologists (Great Britain))"},{"issue":"1\u20132","key":"10.1016\/j.humimm.2017.10.013_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-011-0782-9","article-title":"Association between circulating interleukin-1 beta (IL-1beta) levels and IL-1beta C-511T polymorphism with cervical cancer risk in Egyptian women","volume":"353","author":"Al-Tahhan","year":"2011","journal-title":"Mole. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.humimm.2017.10.013_b0105","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.4049\/jimmunol.179.7.4867","article-title":"Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity","volume":"179","author":"Fontalba","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2017.10.013_b0110","doi-asserted-by":"crossref","first-page":"e31326","DOI":"10.1371\/journal.pone.0031326","article-title":"Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils","volume":"7","author":"Blomgran","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.humimm.2017.10.013_b0115","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00018-010-0335-5","article-title":"Control of infection by pyroptosis and autophagy: role of TLR and NLR","volume":"67","author":"Bortoluci","year":"2010","journal-title":"Cell. Mole. Life Sci.: CMLS"},{"key":"10.1016\/j.humimm.2017.10.013_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2016.09.019","article-title":"Polymorphisms of Interlukin-1beta rs16944 confer susceptibility to myelodysplastic syndromes","volume":"165","author":"Yin","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.humimm.2017.10.013_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000455986","article-title":"The Association between Polymorphism of CARD8 rs2043211 and Susceptibility to arteriosclerosis obliterans in chinese han male population","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Phys., Biochem Pharmacol."},{"issue":"10","key":"10.1016\/j.humimm.2017.10.013_b0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cancergen.2016.09.004","article-title":"Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression","volume":"209","author":"da Silva","year":"2016","journal-title":"Cancer Genet."},{"issue":"8","key":"10.1016\/j.humimm.2017.10.013_b0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2017.10.013_b0140","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1159\/000373960","article-title":"CARD8 rs2043211 polymorphism is associated with gout in a Chinese male population","volume":"35","author":"Chen","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.humimm.2017.10.013_b0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0145-2126(03)00261-3","article-title":"Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival","volume":"28","author":"Alexandrakis","year":"2004","journal-title":"Leukemia Res."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2017.10.013_b0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00407-0","article-title":"Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation","volume":"112","author":"Giedraitis","year":"2001","journal-title":"J. Neuroimmunol"},{"issue":"7","key":"10.1016\/j.humimm.2017.10.013_b0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still's disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2017.10.013_b0160","doi-asserted-by":"crossref","first-page":"530381","DOI":"10.1155\/2014\/530381","article-title":"Investigation of NF-kappaB1 and NF-kappaBIA gene polymorphism in non-small cell lung cancer","volume":"2014","author":"Oltulu","year":"2014","journal-title":"BioMed Res. Int."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917305219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917305219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T11:05:01Z","timestamp":1535281501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885917305219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0198885917305219"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.10.013","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}